Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2012
DOI: 10.1038/ja.2012.81
|View full text |Cite
|
Sign up to set email alerts
|

Pyramidamycins A-D and 3-hydroxyquinoline-2-carboxamide; cytotoxic benzamides from Streptomyces sp. DGC1

Abstract: Four new benzamides, pyramidamycins A-D (2–5) along with the new natural 3-hydroxyquinoline-2-carboxamide (6) were isolated from the crude extract of Streptomyces sp. DGC1. Additionally, five other known compounds namely 2-aminobenzamide (anthranilamide) (1), 4′,7-dihydroxyisoflavanone (7), 2′-deoxy-thymidine, 2′-deoxy-uridine and adenosine were also isolated and identified. The structures of the new compounds 2–6 were elucidated by 1D and 2D NMR studies along with HRMS analyses. The isolated compounds 1–6 con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 30 publications
(16 citation statements)
references
References 24 publications
0
16
0
Order By: Relevance
“…It is well known that the parent compound of II occurs in nature, and an additional source was found recently, as II (R = R´= R´´ = H) was isolated from Streptomyces sp. 6 Concerning the biological activities, derivatives of II have been described recently as substrates for the antibacterial target undecaprenyl pyrophosphate synthase, 7 as modulators of the expression of micro RNAs in neuroblastoma cells which cause cell cycle arrest and apoptosis, 8 as inhibitors for Pseudomonas aeruginosa infections 9 and of SIRT, 10 and of neuronal ion channels. 11 Syntheses and structureactivity relationships of orally active anthranilamide-based factor Xa inhibitors have been studied as well.…”
Section: Introductionmentioning
confidence: 99%
“…It is well known that the parent compound of II occurs in nature, and an additional source was found recently, as II (R = R´= R´´ = H) was isolated from Streptomyces sp. 6 Concerning the biological activities, derivatives of II have been described recently as substrates for the antibacterial target undecaprenyl pyrophosphate synthase, 7 as modulators of the expression of micro RNAs in neuroblastoma cells which cause cell cycle arrest and apoptosis, 8 as inhibitors for Pseudomonas aeruginosa infections 9 and of SIRT, 10 and of neuronal ion channels. 11 Syntheses and structureactivity relationships of orally active anthranilamide-based factor Xa inhibitors have been studied as well.…”
Section: Introductionmentioning
confidence: 99%
“…24,7,8,10,1317,29,52–70 Likewise, including the new bacterial carboxamides 6 and 7 reported herein, over 60 benzamide derivatives have been reported from bacteria, many of which also reportedly display interesting biological and pharmaceutical properties. 71 Importantly, the current study is the first to assess spoxazomicins or oxachelins in the context of neuroprotection against EtOH-induced damage, where corresponding bioactivity comparisons among the analogues tested highlight the importance of the spoxazomicin D ( 2 ) carboxamide and oxachelin C ( 5 ) salicylate as critical to this newly discovered function. While the molecular mechanism and/or specific target of spoxazomicin D ( 2 ) and oxachelin C within this context remains to be determined, it is important to note that structurally related thiazoline-based pulicatins were recently identified as modulators of Ca 2+ influx in a mouse dorsal root ganglion neuronal assay and as high-affinity ligands for the human serotonin 5-HT 2B receptor.…”
Section: Resultsmentioning
confidence: 92%
“…They have been considered to be a rich source of unique bioactive compounds since the discovery of penicillin ( Figure 1) in 1929 [34], which was structurally elucidated in 1945 and introduced as the first antibiotic by Fleming, Chain, and Florey [35]. Today, many microbial-originated antibiotics are available in the market, and more than 120 of the most important medicines in use are obtained from terrestrial microorganisms [36]. A large number of bioactive metabolites are used in medicine, agriculture, and industry, but about 100 of them are used for therapeutic purposes, herbicidal activity, growth-promoting agents, or tools for biochemistry [37].…”
Section: Microbial Sources In Drug Discoverymentioning
confidence: 99%